Xian Jiang

Oct 12, 2024 | pubs.rsc.org | Xian Jiang |Yi Ren |Caikang Wang |Yufei Wang

Unique one-pot strategy for PdH0.706 nanoparticles with enhanced stability and activity towards ethanol oxidation reaction We present a novel and universal solvothermal method for fabricating high-hydrogen-content PdH0.706 nanoparticles, which demonstrate 1.53 A mg⁻¹ ethanol oxidation activity, 1.39 and 1.76 times higher than hydrogen-free Pd and commercial Pd black, respectively, along with superior stability and CO tolerance under alkaline conditions.

May 26, 2023 | hindawi.com | Yuanyuan Xu |Zhixuan Li |Xian Jiang

Background. The pathogenesis of atopic dermatitis (AD) is associated with proinflammatory cytokines and the JAK/STAT signaling pathway. Upadacitinib, an approved oral JAK1 inhibitor, has been investigated in some clinical trials and observational studies of AD. However, the efficacy and safety profile of upadacitinib for AD is still unclear, as few previous meta-analyses evaluated upadacitinib alone. Purpose.